Clinical Trial Update: Gemcitabine With Peptide Vaccine Therapy in Treating Patients With Bile Duct Cancer [Phase 1]

View source ↗

Summary

Phase 1 study evaluating gemcitabine in combination with a peptide vaccine therapy for cholangiocarcinoma (bile duct cancer); the trial is currently suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Peptide vaccine therapy

Snippet

Sponsor: Akita University Hospital | Conditions: Bile Duct Cancer | Phase 1 | Status: SUSPENDED